;   Medical Translation Insight: Understanding submissions - ForeignExchange Translations

Understanding submissions

I read an interesting article recently entitled, "Understanding the 505(b)(2) Approval Process." What I found most interesting was the clear and concise explanation of the clinical trial and the submission processes for the FDA. The clinical trial process is not new to me. I've been working with clients to help them with this work for over 10 years. Part of the submission section was new to me.

For me and most other medical translation professionals, the basics of the submission process are clear. However, I did not know that there were three separate paths a company could pursue, based on their product – the main one is 505(b)(1). This path is for new drugs. The second one is 505(b)(2). This is for drugs that are not completely new products, yet they are not generics. Drugs chosen for this path may have the same active ingredients as a previously approved drug, but now the drug is formulated in a different delivery mechanism or with a different indication.

Why is this significant? This second path allows a developer to come up with a new approach for a previously approved drug, while using the original clinical data. This is a huge benefit. The cost and time are radically reduced.

The third path for submissions is for generics. Generics have an abbreviated process for approval (called the ANDA versus the NDA). A generic manufacturer only needs to complete studies that demonstrate the generic product to be bioequivalent to the original product. Again, this is a major time and money saver.

This new understanding will better prepare me for my work with our clients. Our clients have clinical and submission needs, and they come to us to help them through it. In my seven years at ForeignExchange, I have helped many. This article will be another bit of knowledge to help me down that path.

You can read the full article here: http://www.cedrugstorenews.com/userapp//lessons/page_view_ui.cfm?lessonuid=&pageid=D5B9DCC03556C28694B51161244B36F9.

Entry by Bob Muzerall

Learn how ForeignExchange Translations helps drug and device companies conduct clinical trials in countries around the world.

1 Comment:

  1. John Aadam said...
    Translators play a vital role in any business. They help in conveying the information precisely from one language to another in various countries across the globe. These translators offer different services. Usually, translators deal with written communication.

    Medical translator helps to enhance communication between hospital administration as well as patients. Medical translators also assist in translating patient’s periodical files and hospital information materials into patient’s languages. They have a strong knowledge of medical and the medical terms in both languages, plus the cultural feature relating to how the patient accepts the information. Moreover, these translators are graduates in the language they are translating with; although, that is not adequate for medical translations. A professional medical translator will have a wide knowledge in the healthcare field.

Post a Comment


Services | Resources | Company | Contact Us | Blog | Home

(c) Copyright 2010, ForeignExchange Translations, Inc.